{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:25:38Z","timestamp":1749939938017},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:p>Some types of schizophrenia have been associated with repetitive movements lacking specific purpose, also known as stereotyped behavior. Dopamine agonists (D<jats:sub>2<\/jats:sub>) and noncompetitive <jats:italic toggle=\"yes\">N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate receptor antagonists (e.g. ketamine) have been administered in rodent models to induce stereotyped behavior that resembles some motor symptoms of schizophrenia. Recently, a relationship has been found between 5-HT6 receptors (5-HT6Rs) and dopaminergic activity. The present study evaluates the effect of ketamine (5 and 10\u2009mg\/kg), alone and in combination with the 5-HT6R agonist E-6837, on the climbing behavior of male mice. Ketamine was administered with an acute (1 day) and subchronic (5 day) scheme. Later, these doses and schemes were combined with an acute scheme of E-6837 (5 and 10\u2009mg\/kg). With both the acute and the subchronic schemes, ketamine increased climbing behavior at a dose of 10\u2009mg\/kg, and this effect was reversed by E-6837 (at 5 and 10\u2009mg\/kg). The present results suggest that there is an interaction between <jats:italic toggle=\"yes\">N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate and 5-HT6 receptors in the regulation of climbing behavior. Further research is necessary to provide more evidence on this interaction.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000235","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T17:18:27Z","timestamp":1461086307000},"page":"485-488","source":"Crossref","is-referenced-by-count":5,"title":["Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior"],"prefix":"10.1097","volume":"27","author":[{"given":"Alfredo","family":"Briones-Aranda","sequence":"first","affiliation":[{"name":"Faculty of Human Medicine, Autonomous University of Chiapas, Tuxtla Guti\u00e9rrez, Chiapas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 E.","family":"Su\u00e1rez-Santiago","sequence":"additional","affiliation":[{"name":"School of Medicine, National Polytechnic Institute, Mexico City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofir","family":"Picazo","sequence":"additional","affiliation":[{"name":"School of Medicine, National Polytechnic Institute, Mexico City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Castellanos-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Faculty of Human Medicine, Autonomous University of Chiapas, Tuxtla Guti\u00e9rrez, Chiapas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity","volume":"28","author":"Becker","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R2-20230914","first-page":"5","article-title":"Interaction of nmda and 5-HT6 receptors in the preclinical investigation of schizophrenia-related cognitive changes","volume":"22","author":"Briones","year":"2015","journal-title":"Psiquiatr Biol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00213-002-1046-x","article-title":"Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice","volume":"162","author":"Briones-Aranda","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1007\/s00213-015-3946-6","article-title":"PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments","volume":"232","author":"Casta\u00f1\u00e9","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.psychres.2014.12.048","article-title":"Abnormal movements in first-episode, non affective psychosis: dyskinesias, stereotypies, and catatonic-like signs","volume":"1","author":"Compton","year":"2015","journal-title":"Psychiatry Res"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/0269881113492029","article-title":"Comparison of the MK-801-induced increase in non-rewarded appetitive responding with dopamine agonists and locomotor activity in rats","volume":"27","author":"Davis-MacNevin","year":"2013","journal-title":"J Psychopharmacol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4196\/kjpp.2009.13.2.71","article-title":"YKP1447, a novel potential atypical antipsychotic agent","volume":"13","author":"Dong","year":"2009","journal-title":"Korean J Physiol Pharmacol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0269881115573809","article-title":"Impact of sub anesthetic doses of ketamine on AMPA-mediated responses in rats: an in vivo electrophysiological study on monoaminergic and glutamatergic neurons","volume":"29","author":"El Iskandrani","year":"2015","journal-title":"J Psychopharmacol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2015.04.046","article-title":"Deconstructing 5-HT6 receptor effects on striatal circuit function","volume":"299","author":"Eskenazi","year":"2015","journal-title":"Neuroscience"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0893-133X(99)00043-3","article-title":"Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain","volume":"21","author":"Healy","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s007020050168","article-title":"Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists","volume":"106","author":"Hesselink","year":"1999","journal-title":"J Neural Transm"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejphar.2011.03.050","article-title":"Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain","volume":"660","author":"Ikeda","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00210-015-1141-2","article-title":"Antidepressant-like activity of EMD 386088, a 5-HT(6) receptor partial agonist, following systemic acute and chronic administration to rats","volume":"388","author":"Jastrz\u0119bska-Wi\u0119sek","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-010-1854-3","article-title":"E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat","volume":"213","author":"Kendall","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s11064-014-1419-7","article-title":"Behavioral and neurochemical changes induced by repetitive combined treatments of ketamine and amphetamine in mice","volume":"39","author":"Lai","year":"2014","journal-title":"Neurochem Res"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00213-006-0344-0","article-title":"Mapping the central effects of ketamine in the rat using pharmacological MRI","volume":"186","author":"Littlewood","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1016\/j.bmcl.2005.06.067","article-title":"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1 H-indoles as novel 5-HT6 receptor agonists","volume":"15","author":"Mattsson","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"18125","DOI":"10.1523\/JNEUROSCI.2382-13.2013","article-title":"D1 dopamine receptor coupling to PLC\u03b2 regulates forward locomotion in mice","volume":"33","author":"Medvedev","year":"2013","journal-title":"J Neurosci"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-4159.2004.02358.x","article-title":"NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR","volume":"89","author":"Olszewski","year":"2004","journal-title":"J Neurochem"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnint.2015.00037","article-title":"Elevated dopamine alters consummatory pattern generation and increases behavioral variability during learning","volume":"9","author":"Rossi","year":"2015","journal-title":"Front Integr Neurosci"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1213\/01.ane.0000247792.03959.f1","article-title":"The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study","volume":"103","author":"Sakamoto","year":"2006","journal-title":"Anesth Analg"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1017\/S1461145714000509","article-title":"TAAR1-dependent effects of apomorphine in mice","volume":"17","author":"Sukhanov","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuropharm.2012.08.025","article-title":"Evidence for a role of a dopamine\/5-HT6 receptor interaction in cocaine reinforcement","volume":"65","author":"Valentini","year":"2013","journal-title":"Neuropharmacology"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroscience.2009.07.061","article-title":"Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus","volume":"164","author":"West","year":"2009","journal-title":"Neuroscience"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201608000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:03:52Z","timestamp":1694736232000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201608000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000235","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}